The analysis suggested that TECs might promote tumor growth and progression through the interaction of COL4A1/COL4A2 with their partner receptors (ITGAV + ITGB8 and ITGA3 + ITGB1) on epithelial cells (Figs. 4J and S5B). The gene discussed is COL4A2; the disease is neoplasm.